Use of cdk4/6 inhibitor in combination with egfr inhibitor in the preparation of medicament for treating tumor diseases
AssigneeJiangsu Hengrui Medicine Co., Ltd.
InventorsLei ZHANG, Changyong YANG, Cheng LIAO, Lianshan ZHANG
Life of this patent
Estimating the term…
Abstract
Provided in the present invention is a use of CDK4/6 inhibitor in combination with EGFR inhibitor in the preparation of a medicament for treating tumor diseases. In particular, provided in the invention is a use of a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) in combination with a human epidermal growth factor receptor inhibitor (EGFRi) for the preparation of a medicament for preventing or treating tumor diseases.
Claims14
A method for preventing or treating tumor disease, comprising administering to a subject in need thereof an effective amount of a CDK4/6 inhibitor and an EGFR inhibitor.
A pharmaceutical composition, which comprises a CDK4/6 inhibitor and an EGFR inhibitor, and one or more pharmaceutical carriers, excipients or diluents.
Dependencies are inferred from the claim text.